+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Preparation of high-purity and safe autologous plasmin and its clinical application



Preparation of high-purity and safe autologous plasmin and its clinical application



Nippon Ganka Gakkai Zasshi 107(11): 709-718



Purpose: To report an improved preparation of safer and highly-purified autologous plasmin and to demonstrate its clinical applications. Methods: Prior to clinical application, animal experiments were carried out. In addition, the activity of plasmin in the vitreous cavity after injection was measured serially. In preparation for clinical use, the proteinase inhibitors aprotinin and benzamidine were used for suppression of protein denaturation. The samples were incubated for 48 hours to check for contamination. The preparation was applied to patients with idiopathic macular hole and diabetic macular edema. Results: The plasmin detached the vitreous body from the inner limiting membrane of the retina without any ill effects in animal experiments. The specific activity reached a peak in 5apprx10 minutes and decreased rapidly thereafter. By adding a suppressor of protein denaturation in the purification process, 0.2 IU (0.1 ml) of high-purity plasmin could be prepared from each patient. No bacterial contamination was noted. Complete vitreous detachment could be induced in two clinical cases. Urokinase was used instead of streptokinase to activate plasminogen. Conclusions: Vitreous detachment is considered to be induced safely and consistently by injection of plasmin prepared using a protein denaturation suppressor and activated with urokinase. This method is expected to be of clinical value.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012443831

Download citation: RISBibTeXText

PMID: 14661545


Related references

Practical analysis of high-purity chemicals-I Preparation and characterization of high-purity EDTA. Talanta 17(9): 785-799, 1970

Laboratory for preparation of high purity clinical chemicals. Clinical Chemistry 18(5): 446-448, 1972

Preparation and quality control of high purity iodine 123 for clinical use. International Journal of Applied Radiation and Isotopes 27(5-6): 319-323, 1976

Preparation and quality control of high purity 123I for clinical use. International Journal of Applied Radiation and Isotopes 27(5-6): 319-323, 1976

Preparation of high purity IgG and its application in screening for clones positive for Vibrio succinogenes L-asparaginase gene. Chinese Journal of Biotechnology 5(1): 19-26, 1989

Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes. Indian Journal of Hematology and Blood Transfusion 24(2): 54-58, 2008

Autologous plasmin for intravitreal injection without associated vitrectomy: a simple preparation method with streptokinase. Archivos de la Sociedad Espanola de Oftalmologia 83(3): 153-154, 2008

On-line purity monitoring in high-speed counter-current chromatography: application of HSCCC-HPLC-DAD for the preparation of 5-HMF, neomangiferin and mangiferin from Anemarrhena asphodeloides Bunge. Journal of Pharmaceutical and Biomedical Analysis 44(1): 96, 2007

Differential scanning calorimetry as a general method for determining the purity and heat of fusion of high-purity organic chemicals. Application to 95 compounds. Analytical Chemistry 41(2): 330-336, 1969

From cryoprecipitate to virus-safe high-purity concentrate. Seminars in Thrombosis and Hemostasis 28(Suppl. 1): 25-30, 2002

Methods for factor viii preparation 2. preparation of a high purity concentrate by controlled pore glass chromatography. Sangre 29(4A): 457-466, 1984

Production of smallpox vaccine of high bacteriological purity from heifers; resistance of the vaccine virus to merthiolate and its application to the preparation of dry refined vaccine. Annales de la Societe Belge de Medecine Tropicale 34(1): 21-42, 1954

Safe direct synthesis of high purity H2O2 through a H2/O2 plasma reaction. Angewandte Chemie 52(32): 8446-8449, 2013

Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII. Vox Sanguinis 36(6): 369-374, 1979

A very-high-purity von Willebrand factor preparation containing high-molecular-weight multimers. Vox Sanguinis 76(2): 85-89, 1999